These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3010492)

  • 21. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
    Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
    Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
    Sato T; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superoxide dismutase triggers activation of "primed" platelets.
    Iuliano L; Praticò D; Ghiselli A; Bonavita MS; Violi F
    Arch Biochem Biophys; 1991 Aug; 289(1):180-3. PubMed ID: 1910314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
    Bernstrom K; Malcolm K; McGee J; Maclouf J; Levy-Toledano S; Falck JR; Fitzpatrick FA
    Mol Pharmacol; 1991 Feb; 39(2):114-9. PubMed ID: 1847490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
    Heyns Adu P; Eldor A; Yarom R; Marx G
    Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
    Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
    Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenetic analysis of three cases with a bleeding disorder characterized by defective platelet aggregation induced by Ca2+ ionophores.
    Fuse I; Higuchi W; Uesugi Y; Aizawa Y
    Br J Haematol; 2001 Mar; 112(3):603-8. PubMed ID: 11260060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.